Twist Bioscience saw the biggest consensus price target revision the sweep measured. The mean target jumped from $121 to $150, while shares trade at $160. Twelve analysts span the published range, from $45 to $215. That was the largest move among 458 names in the sweep of 9 October. This reflects a consensus of published targets, not a forecast from this channel.
Want a channel or video like this for your brand or business? Contact studio@mixinumhq.com.
The narration is AI-written from this episode's data and read by a synthetic text-to-speech voice. Not financial advice. Every number here is public — check it.
More
Mixinum Financial Review: https://thao.funnymoment.net/mixinum
